Cytokine-blocking monoclonal antibody helps prevent asthma exacerbations
A recent clinical trial showed a 56% reduction in yearly asthma exacerbations when patients with severe asthma were treated...
A recent clinical trial showed a 56% reduction in yearly asthma exacerbations when patients with severe asthma were treated...